CymitQuimica logo

CAS 952652-79-8

:

Sortieren nach

Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 Produkte.
  • Valsartan Related Compound B (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)

    CAS:
    Aromatic or modified aromatic drugs with nitrogen heter
    Formel:C23H27N5O3
    Farbe und Form:White Powder
    Molekulargewicht:421.21139
  • Valsartan n-Propyl

    CAS:
    Formel:C23H27N5O3
    Reinheit:98%
    Farbe und Form:Solid
    Molekulargewicht:421.4922

    Ref: IN-DA00IIWL

    10mg
    157,00€
    25mg
    221,00€
    50mg
    331,00€
    100mg
    658,00€
  • Valsartan EP Impurity C (Valsartan USP Related Compound B)

    CAS:
    Formel:C23H27N5O3
    Farbe und Form:Off-White Solid
    Molekulargewicht:421.50

    Ref: 4Z-V-026

    5mg
    Nachfragen
    10mg
    508,00€
    25mg
    825,00€
    50mg
    1.153,00€
    100mg
    Nachfragen
  • Valsartan Impurity 46

    CAS:
    Formel:C25H31N5O3
    Farbe und Form:Off-White Solid
    Molekulargewicht:449.56

    Ref: 4Z-V-0268

    5mg
    Nachfragen
    10mg
    Nachfragen
    25mg
    Nachfragen
    50mg
    Nachfragen
    100mg
    Nachfragen
  • Valsartan n-Propyl Impurity

    Kontrolliertes Produkt
    CAS:
    <p>Impurity Valsartan Related Compound B<br>Applications Valsartan n-Propyl is an impurity in the synthesis of Valsartan (V095750). Valsartan USP Related Compound B.<br>References Hillaert, S., et al.: J. Pharm. Biomed. Anal., 31, 329 (2003), Carlucci, G., et al.: Anal. Lett., 33, 2491 (2000), Cagigal, E., et al.: Talanta, 54, 1121 (2001),<br></p>
    Formel:C23H27N5O3
    Farbe und Form:White
    Molekulargewicht:421.49

    Ref: TR-V095770

    10mg
    363,00€
    25mg
    899,00€
    100mg
    2.480,00€
  • Valsartan EP Impurity C

    CAS:
    Formel:C23H27N5O3
    Molekulargewicht:421.49

    Ref: ST-EA-CP-V3003

    10mg
    Nachfragen
    25mg
    Nachfragen
    50mg
    Nachfragen
    100mg
    Nachfragen
  • N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine

    CAS:
    <p>N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine (GW1929) is a potent vasodilator that is used for the treatment of hypertension. It is synthesized by condensation of sodium hydroxide with 2-(4′-chlorophenyl)piperazine followed by methyl esterification and chloride acylation. The synthesis of GW1929 has been accomplished in two steps: carbonate cyclization and valsartan hydrolysis. In the first step, the carboxylic acid group of GW1929 was converted to its corresponding chloride compound which was then reacted with methyl bromide to yield the desired product. The second step involved hydrolysis of GW1929 with potassium carbonate, after which it was oxidized with azide to form an ester. Sodium</p>
    Formel:C23H27N5O3
    Reinheit:Min. 95%
    Farbe und Form:White Powder
    Molekulargewicht:421.49 g/mol

    Ref: 3D-IO28664

    1mg
    233,00€
    2mg
    341,00€
    5mg
    486,00€
    10mg
    748,00€
    25mg
    1.356,00€